These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2093095)

  • 1. Evidence suggesting that the 5-HT2 antagonist ICI 169,369 activates vagal afferents and in addition has a central hypotensive action in anaesthetized rats.
    Pires JG; Ramage AG
    J Auton Pharmacol; 1990 Dec; 10(6):345-51. PubMed ID: 2093095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors.
    Lacolley P; Owen JR; Sandock K; Lewis TH; Bates JN; Robertson TP; Lewis SJ
    Neuroscience; 2006 Nov; 143(1):273-87. PubMed ID: 17029799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of DAU 6215, a novel 5-HT3 receptor antagonist, on the cardiovascular system in anaesthetized and pithed rats.
    Malinowska B; Pawlak D; Buczko W
    Agents Actions; 1992 Jul; 36(3-4):230-6. PubMed ID: 1529806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of DV-7028, a novel serotonin 5-HT2 receptor antagonist on the cardiovascular system in rats.
    Pawlak D; Małyszko J; Myśliwiec M; Takada A; Buczko W
    Acta Physiol Hung; 1996; 84(3):325-6. PubMed ID: 9219625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central administration of 5-HT activates 5-HT1A receptors to cause sympathoexcitation and 5-HT2/5-HT1C receptors to release vasopressin in anaesthetized rats.
    Anderson IK; Martin GR; Ramage AG
    Br J Pharmacol; 1992 Dec; 107(4):1020-8. PubMed ID: 1467825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of the effects of some 5-HT2 receptor antagonists on central sympathetic outflow and blood pressure in anaesthetised cats.
    Ramage AG
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):601-7. PubMed ID: 3149720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardio-respiratory reflexes evoked by phenylbiguanide in rats involve vagal afferents which are not sensitive to capsaicin.
    Dutta A; Deshpande SB
    Acta Physiol (Oxf); 2010 Sep; 200(1):87-95. PubMed ID: 20331538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of DOI, a putative 5-HT2 receptor agonist in the rat.
    Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Laubie M; Schmitt H
    Eur J Pharmacol; 1989 Sep; 168(3):369-74. PubMed ID: 2583242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that activation of 5-HT2 receptors in the forebrain of anaesthetized cats causes sympathoexcitation.
    Anderson IK; Martin GR; Ramage AG
    Br J Pharmacol; 1995 Sep; 116(2):1751-6. PubMed ID: 8528555
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of reflexly evoked vagal bradycardias by central 5-HT1A receptors in anaesthetized rabbits.
    Skinner MR; Ramage AG; Jordan D
    Br J Pharmacol; 2002 Nov; 137(6):861-73. PubMed ID: 12411418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-adrenoceptor blockade and sympathetic neurotransmission in the pithed rat.
    Majewski H; Murphy TV
    J Hypertens; 1989 Dec; 7(12):991-6. PubMed ID: 2576431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies in vivo with ICI 169,369, a chemically novel 5-HT2/5-HT1C receptor antagonist.
    Blackburn TP; Cox B; Thornber CW; Pearce RJ
    Eur J Pharmacol; 1990 May; 180(2-3):229-37. PubMed ID: 2163866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmitter mechanisms in vagal afferent-induced reduction of lower oesophageal sphincter (LOS) pressure in the rat.
    Kawahara H; Blackshaw LA; Nisyrios V; Dent J
    J Auton Nerv Syst; 1994 Sep; 49(1):69-80. PubMed ID: 7963267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the cardiovascular effects of the 5-HT1A receptor agonist flesinoxan with that of 8-OH-DPAT in the rat.
    Dreteler GH; Wouters W; Saxena PR
    Eur J Pharmacol; 1990 May; 180(2-3):339-49. PubMed ID: 2142096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vagal afferent-mediated inhibition of a nociceptive reflex by i.v. serotonin in the rat. II. Role of 5-HT receptor subtypes.
    Meller ST; Lewis SJ; Brody MJ; Gebhart GF
    Brain Res; 1992 Jul; 585(1-2):71-86. PubMed ID: 1511336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antihypertensive profile of the angiotensin AT1 receptor antagonist, GR138950, and the influence of potential homeostatic compensatory mechanisms in renal hypertensive rats.
    Anderson IK; Drew GM
    Br J Pharmacol; 1998 Nov; 125(6):1236-46. PubMed ID: 9863652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart.
    García M; Morán A; Martín ML; Ortizde Urbina AV; San Román L
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1199-206. PubMed ID: 17880377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR-14134, a new benzothiazepine with central hypotensive action.
    Prieto P; Carrón R; Montero MJ; Morán A; Román LS
    Pharmacology; 1995 Aug; 51(2):84-95. PubMed ID: 8584576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vagally mediated bradycardiac effect of prazosin in anaesthetized rats.
    Paakkari I; Puurunen J
    Eur J Pharmacol; 1984 Oct; 105(3-4):223-8. PubMed ID: 6510469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.